Pharmacists in Hurst, Texas


30 Pharmacists found in Hurst
female pharmacist

Prashanthi Kowkutla


Pharmacist
720 W Pipeline Rd, Hurst, TX 76053
817-199-3525    

male pharmacist

Ryan Mallory


Pharmacist
1400 Precinct Line Rd, T-1766, Hurst, TX 76053
817-282-8917    

male pharmacist

Scott Lane Harvey


Pharmacist
3132 Oakdale Dr, Hurst, TX 76054
817-319-8879    



female pharmacist

Shana Marie Santana, PHARMD


Pharmacist
780 W Bedford Euless Rd, Hurst, TX 76053
817-282-0820    

female pharmacist

Shannan Marie Busby, PHARMD


Pharmacist
720 W Pipeline Rd, Hurst, TX 76053
817-799-3525    

female pharmacist

Ms. Sharita Washington, RPH


Pharmacist
720 W Pipeline Rd, Hurst, TX 76053
817-799-3525     817-799-3524

female pharmacist

Stephanie O'brien


Pharmacist
612 Grapevine Hwy, Hurst, TX 76054
817-281-0456     817-281-0489

male pharmacist

Stephen Mitchell Bulgerin


Pharmacist
1233 Precinct Line Rd, Hurst, TX 76053
817-595-2484    

female pharmacist

Thuy Tran


Pharmacist
1233 Precinct Line Rd, Hurst, TX 76053
817-595-2484    

male pharmacist

Travis Allison, PHARM.D.


Pharmacist
720 W Pipeline Rd, Hurst, TX 76053
817-799-3525    

female pharmacist

Unknown Jenny Ann George


Pharmacist
780 W Bedoford Euless Rd, Hurst, TX 76053
817-282-0308    

female pharmacist

Wendy J Scaggs, R.PH.


Pharmacist
780 W Bedford Euless Rd, Hurst, TX 76053
817-282-0308     817-282-1129

female pharmacist

Yanci Deng, PHARM D


Pharmacist
780 W Bedford Euless Rd, Hurst, TX 76053
817-282-0308    

female pharmacist

Dr. Yvette Dayon Harden, PHARMD, RPH


Pharmacist
708 E Pipeline Rd, Hurst, TX 76053
817-285-8851    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.